Loading…
← CockpitCompetitor Analysis › AFYA Afya Limited Class AOpen in the cockpit ↗

Afya Limited Class AAFYACompetitor analysis, valuation and peers

United States · USD·Consumer Discretionary›Other Consumer Services

Operates medical schools in Brazil and provides digital education and practice-management tools for physicians.

≈ Brazil's largest medical-education companyMomentum laggard 17
Mkt cap
$960M
US dollars, full cap
Free float
16%
of shares outstanding
$/day
$5.81M
20-day average traded
Fwd P/E
5.9×
forward earnings
ROIC−WACC
+7.1 pp
WACC 6.5%
Hurdle
-40 pp
Req g minus delivered
Next earnings
6 days
12 Nov 2026
Close · USD$10.50
1D+3.5%
1W+0.5%
1M-25.8%
3M-21.9%
6M-24.6%
YTD-31.9%
1Y-26.7%
ATR %6.8%
Beta0.28
52w lowhigh35.0% off high

What Afya does

Operates medical schools in Brazil and provides digital education and practice-management tools for physicians.

Earns monthly tuition from students in its medical programmes, so income depends on the number of seats Brazil's regulator lets it offer and how many it fills. It has expanded largely by buying other medical schools and then adding seats, with subscription-style courses sold to practising doctors alongside.

In one line: Brazil's largest medical-education company.

Products and services

  • Undergraduate medical school programs
  • Continuing medical education/digital courses
  • Physician practice-management software

Customers

  • Medical students in Brazil
  • Practicing physicians

Where it sits in the supply chain

  • Consumer discretionary
  • For-profit education
  • Medical education & physician digital…

What could go right

  • Brazil physician shortage/medical seat scarcity
  • Cross-sell of digital tools to physician base

What could go wrong

  • Brazilian regulatory/education policy risk
  • Currency (BRL) volatility

Moat: narrow (regulatory licence, scale, brand). Brazil tightly regulates new medical-school seats, giving incumbents like Afya a scarce-license advantage.

Headquarters: Nova Lima, Brazil · Founded: 2003 · Employees: 9,395

Named competitors

  • Cogna Educacao private or unlisted
  • Ser Educacional private or unlisted
  • YDUQS Participacoes private or unlisted

Afya at a glance

Size Afya (AFYA) is a United States Consumer Discretionary company (Other Consumer Services) with a market value of $960M, the 2275th largest of 3,117 United States companies the cockpit tracks. Shares closed at $10.50 on 6 Nov 2026.

Performance Over six months the shares fell 24.6%, against -15.3% for the median peer and -1.1% for the United States market (cap-weighted) — 8th lowest of 21 in its peer set.

Growth Revenue grew 17.0% over the last twelve months (peer median +4.1%); the operating margin is 32.5% (peer median 13.0%).

Valuation It trades at 5.9× forward earnings against a peer median of 15.7× (cheapest of 16).

Price implies For today's price to make sense, revenue must grow about -16% a year for seven years (Req g). Recent delivered growth is +23%, so the hurdle is -40 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 7.1 points above its cost of capital (6.5% WACC).

Short interest Short interest is 0.8% of the free float (15 Oct 2026).

Next results Next results expected around 12 Nov 2026 (exchange calendar; dates can move).

Relative performance

8010011 May 202611 Aug 20266 Nov 2026Peer median 87AFYA 75
Six months, rebased to 100: Afya against the median of its 20 peers (local-currency closes).

Afya financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$725M$662M$613M$576M$451M
Revenue growth—+8%+6%+28%—
Gross profit$464M$427M$387M$354M$285M
EBITDA$305M$284M$257M$208M$176M
Net income$148M$135M$117M$77.3M$72.3M
Free cash flow$209M$189M$194M$152M$132M
Capital expenditure$58.6M$65.2M$72.8M$49.1M$57.5M
Total debt$602M$569M$514M$551M$514M

Quarterly statements and history in the cockpit →

Afya competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-20%0%SATSALVDMTRNWEB002638301215603402TRIP0308MAD000796000430STRA600593000888ACAD0027076001380697002033AFYA6-month return →1-month return →
Up and to the right = strong over both horizons. Afya is the large dot.

Fundamentals: revenue growth against valuation

-20%-10%0%+10%+20%25×50×75×SATSALVDMTRNWEB603402TRIP0308MADSTRA000888ACAD0027076001380697002033AFYARevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Afya is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%SATSALVDMTRNWEB603402TRIP0308MADSTRA0008880027076001380697AFYAGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Afya is the large dot.

Afya competitors and peer comparison

How Afya compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Afya against its 20 peers (data as of 6 Nov 2026)
MeasureAFYAPeer medianRank in peer set
1-month return-25.8%-1.9%2nd lowest of 21
6-month return-24.6%-15.3%8th lowest of 21
Distance from 52-week high-35.0%-37.4%9th highest of 21
Revenue growth (TTM)+17.0%+4.1%5th highest of 21
Operating margin32.5%13.0%4th highest of 21
Forward P/E5.9×15.7×cheapest of 16
Growth the price implies (Req g, 7 yrs)-16.3%1.5%least demanding of 16
Growth delivered (Del g)+23.2%+15.7%8th highest of 16
Hurdle (Req g minus delivered)-39.5 pp-16.9 pp5th least demanding of 16
ROIC minus cost of capital+7.1 pp+2.8 pp6th highest of 19
EV / EBITDA4.5×7.1×cheapest of 13
Net debt / EBITDA1.3×-0.2×5th most indebted of 13

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Afya AFYAUnited States$960M-25%+17%32%5.9×-16.3%+23.2%
Sats SATS.OLNorway$937M+10%+5%18%15.2×-5.9%+10.6%
Voyageurs du Monde ALVDM.PAFrance$896M+28%+4%8%18.1×1.8%+46.3%
Trainline TRN.LUnited Kingdom$887M-5%+1%27%7.9×-8.0%+46.5%
Webbeds WEB.AXAustralia$871M+45%+20%25%15.7×4.5%+50.3%
Dongguan Kingsun Optoelectronic 002638.SZChina$849M-16%-24%-34%n/an/an/a
CATARC Automotive Proving Ground 301215.SZChina$1.10B-12%+23%43%n/an/an/a
Shaanxi Tourism Culture Industry 603402.SSChina$832M-36%-18%54%18.7×-15.9%+27.6%
TripAdvisor TRIPUnited States$820M-38%-4%5%10.1×-6.6%+25.6%
China Travel International Investment Hong Kong 0308.HKHong Kong$809M0%-7%11%23.4×5.4%+15.7%
Mader MAD.AXAustralia$806M-29%+15%9%15.7×5.2%+26.9%
Caissa Tourism 000796.SZChina$805M-36%+42%-10%n/an/an/a
Zhang Jia Jie Tourism 000430.SZChina$1.15B-22%+20%-81%n/an/an/a
Strategic Education STRAUnited States$1.16B-35%+4%16%7.9×-12.6%+4.3%
Dalian Sunasia Tourism 600593.SSChina$793M+19%+5%32%n/an/an/a
Emei Shan Tourism 000888.SZChina$789M-16%-8%15%21.7×3.2%+15.1%
AcadeMedia ACAD.STSweden$1.22B+20%+8%7%9.9×-1.8%+8.7%
UTour 002707.SZChina$740M-15%-9%2%76.6×9.7%+33.8%
China CYTS Tours 600138.SSChina$737M-25%+15%3%43.9×1.5%+9.7%
Shoucheng 0697.HKHong Kong$1.33B-27%-1%16%15.5×21.2%+15.3%
Lijiang Yulong Tourism 002033.SZChina$687M-12%+8%37%18.3×0.8%+14.8%

Questions

Who are Afya's main competitors?
Named competitors: Cogna Educacao (private or unlisted), Ser Educacional (private or unlisted), YDUQS Participacoes (private or unlisted). The cockpit's measured peer set (industry) also includes Sats (SATS.OL), Voyageurs du Monde (ALVDM.PA), Trainline (TRN.L), Webbeds (WEB.AX), Dongguan Kingsun Optoelectronic (002638.SZ), CATARC Automotive Proving Ground (301215.SZ).
Is Afya expensive compared with its peers?
On forward p/e it trades at 5.9× against a peer median of 15.7×, cheapest of 16 in its peer set. For today's price to make sense, revenue must grow about -16% a year for seven years (Req g). Recent delivered growth is +23%, so the hurdle is -40 pp: the price already allows for a slowdown.
How has Afya stock performed?
Over six months to 6 Nov 2026 the shares returned -24.6% against -15.3% for the median peer; over one year -26.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.